Table 2.
Patient | Variant | Bioinformatics | Databases |
---|---|---|---|
14,988 Hom; 9754–12388–12970 Het |
c.690C > G; p.Asn230Lys |
CADD: 7.151 (not deleterious) SIFT: tolerated PolyPhen−2: benign Mutation Taster: disease causing Mutation Assessor: neutral Lost 2 ESEs |
rs1060250 ExAC (G): 0.0046 gnomAD genome (G): 0.0145 gnomAD exome (G): 0.0035 NHLBI ESP (G): 0.0175 |
10,471 | c.1123C > A; p.Pro375Thr a |
CADD: 25.1 (deleterious) SIFT: deleterious PolyPhen−2: probably damaging Mutation Taster: disease causing Mutation Assessor: medium risk |
No; 0/542 controls |
17,410 | c.816−18C > T a | Abnormal quantile signal at acceptor splice site |
rs754179345; 0/542 controls ExAC (T): 1.67E−05 gnomAD genome (T): 6.47E−05 gnomAD exome (T): 1.63E−05 NHLBI ESP (G): no data |
15,301 | c.1290 + 44G>Aa | Lost 1 ESE |
rs774937771 ExAC (G): no data gnomAD genome (G): 9.69E−05 gnomAD exome (G): 8.43E−06 NHLBI ESP (G): no data |
Abbreviations: Hom, homozygous; Het, heterozygous; ESE, Exon splicing enhancer.
bold, likely pathogenic variant.
De novo.